Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases

被引:190
作者
Russell, REK
Thorley, A
Culpitt, SV
Dodd, S
Donnelly, LE
Demattos, C
Fitzgerald, M
Barnes, PJ
机构
[1] Natl Heart & Lung Inst, Dept Thorac Med, Imperial Coll, London SW3 6LY, England
[2] Bayer Pharmaceut, Stoke Poges SL24AE, Bucks, England
关键词
chronic obstructive pulmonary disease;
D O I
10.1152/ajplung.00020.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a common lung disease with cigarette smoking as the major etiological factor, but only 15% of smokers develop COPD. Destruction of lung elastin observed in COPD is mediated by many enzymes, including cysteine, serine, and matrix metalloproteinases (MMP). The contribution of these enzymes to the lung elastolytic load, released from alveolar macrophages collected from nonsmokers, healthy smokers, and COPD patients, was examined by radiolabeled elastin as substrate in the presence of specific enzyme inhibitors. The activity of MMP was further examined by zymography and Western blotting. COPD macrophages degraded more elastin than either of the other groups. Elastolysis was greatest in the initial 24 h. Through the 72-h culture period, the contribution to elastolysis of serine elastases decreased, MMP increased, and cysteine elastases remained constant. The increased release of elastolytic enzymes in COPD subjects may explain why some smokers develop COPD. This difference may be due to unknown susceptibility factors. Serine proteases play a significant role; however, other enzymes, particularly the MMP, deserve further investigation.
引用
收藏
页码:L867 / L873
页数:7
相关论文
共 48 条
[1]   Relationship of alveolar macrophage plasminogen activator and elastase activities to lung function and CT evidence of emphysema [J].
Abboud, RT ;
Ofulue, AF ;
Sansores, RH ;
Muller, NL .
CHEST, 1998, 113 (05) :1257-1263
[2]   Chronic obstructive pulmonary disease: new opportunities for drug development [J].
Barnes, PJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (10) :415-423
[3]  
BARRETT AJ, 1981, ACTA BIOL MED GER, V40, P1513
[4]   STIMULATION OF CYCLIC-AMP PRODUCTION IN HUMAN ALVEOLAR MACROPHAGES INDUCED BY INFLAMMATORY MEDIATORS AND BETA-SYMPATHOMIMETICS [J].
BEUSENBERG, FD ;
VANAMSTERDAM, JGC ;
HOOGSTEDEN, HC ;
HEKKING, PRM ;
BROUWERS, JW ;
SCHERMERS, HP ;
BONTA, IL .
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1992, 228 (01) :57-62
[5]   ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES IN HUMAN-DISEASE [J].
BEVILACQUA, MP ;
NELSON, RM ;
MANNORI, G ;
CECCONI, O .
ANNUAL REVIEW OF MEDICINE, 1994, 45 :361-378
[6]   The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms [J].
Bigatel, DA ;
Elmore, JR ;
Carey, DJ ;
Cizmeci-Smith, G ;
Franklin, DP ;
Youkey, JR .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (01) :130-138
[7]   Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease [J].
Boyle, JR ;
McDermott, E ;
Crowther, M ;
Wills, AD ;
Bell, PRF ;
Thompson, MM .
JOURNAL OF VASCULAR SURGERY, 1998, 27 (02) :354-361
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   CLINICAL-FEATURES AND HISTORY OF THE DESTRUCTIVE LUNG-DISEASE ASSOCIATED WITH ALPHA-1-ANTITRYPSIN DEFICIENCY OF ADULTS WITH PULMONARY SYMPTOMS [J].
BRANTLY, ML ;
PAUL, LD ;
MILLER, BH ;
FALK, RT ;
WU, M ;
CRYSTAL, RG .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (02) :327-336
[10]   MATRIX METALLOPROTEINASE INHIBITORS - A NOVEL CLASS OF ANTICANCER AGENTS [J].
BROWN, PD .
ADVANCES IN ENZYME REGULATION, VOL 35, 1995, 35 :293-301